About Colossal
Colossal is a company based in Austin (United States) founded in 2021 by George M Church. Colossal has raised $617.6 million across 7 funding rounds from investors including Animoca Brands, Animal Capital and Twgglobal. Colossal offers products and services including De-Extinction Services and Conservation Partnerships.
- Total Equity Funding$617.6M (USD)
in 7 rounds
- Latest Funding Round$60M (USD), Series C
Feb 2026
- InvestorsAnimoca Brands
& 34 more
Products & Services of Colossal
Colossal offers a comprehensive portfolio of products and services, including De-Extinction Services and Conservation Partnerships.
Gene editing for the revival of extinct species is offered to support ecosystem restoration.
Collaborations for the protection of keystone species are facilitated to address biodiversity loss.
Apps and channels of Colossal
its YouTube channel Colossal has 128 subscribers.
Funding Insights of Colossal
Colossal has successfully raised a total of $617.6M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $60 million completed in February 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $617.6M
- Total Rounds 7
- Last Round Series C — $60M
- First Round $15M
(Sep 2021)
- Investors Count 35
All 7 funding rounds of Colossal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2026 | $60M | Series C | – | – | |
| Sep 2025 | $120M | Series C | – | – | |
| Jan 2025 | $200M | Series C | – | – | |
| Jan 2023 | $162.6M | Series B | – | Breyer Capital, US Innovative Technology Fund | |
| Oct 2022 | – | Series A | – | – | |
| Mar 2022 | $60M | Series A | – | Thomas Tull, At One Ventures | |
| Sep 2021 | $15M | Seed | – | Thomas Tull |
35 investors in total: 26 institutional and 9 angel.
Investors in Colossal
Colossal has secured backing from 35 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Animoca Brands, Animal Capital and Twgglobal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm | – | breyercapital.com | Menlo Park, United States | |
Venture capital fund investment in AI, machine learning, and cybersecurity startups | – | usinnovativetechnologyfund.tcc.mode | - | |
Investments are focused across multiple sectors by the firm. | – | wrg.vc | Seattle, United States | |
Venture capital firm | – | iqt.org | Washington, Dc, United States | |
Investment firm focused on finance and technology opportunities. | – | peak6.com | - | |
Early-stage life sciences and tech focused VC firm investing primarily in the US | – | boldcapitalpartners.com | Santa Monica, United States | |
Tech & Life Science focused VC firm investing in the US | – | jazzvp.com | San Francisco, United States | |
Venture capital firm focusing on multiple industry | 2021 | animalcapital.com | New York, United States | |
- | – | atoneventures.com | - | |
Private equity investments and corporate advisory services are managed. | – | greensandsequity.com | San Francisco, United States |
Investor details for Colossal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Colossal
105 people are tracked at Colossal (18 in leadership, 73 in board & advisors, 14 in team).
| Name | Role | Group |
|---|---|---|
George M Church | Co-Founder | Leadership |
Sara Ord | Director, Species Restoration | Leadership |
Sam Singer | CFO | Leadership |
Leyi Li | Head of Embryology | Leadership |
Jillian McCall | Marketing Director | Leadership |
Adam Milne | COO | Leadership |
Kent Wakeford | Special Executive Advisor to CEO | Leadership |
Brian Beard | Co-Founder & Chief Legal Officer | Leadership |
Andrew Busey | Co-Founder & Chief Product Officer | Leadership |
Sarah Grant | Chief of Staff | Leadership |
Ben Lamm | Founder & CEO | Leadership |
Jeffery Miles | Sr. Director, IT & Security | Leadership |
Chris Klee | Executive Vice President Of Marketing And Design | Leadership |
Yi-Hsien Chen | Director Of Cell, Engineering And Production Team | Leadership |
David Brooks | Head Of Content Production And Programming | Leadership |
Cheryl Noga | Director, Head Of Talent Acquisition | Leadership |
Amanda Bastawros | Head, HR | Leadership |
Anna Keyte | Species Director, Dodo Lead | Leadership |
John McKinley | Executive Advisor | Board & advisors |
Elinor Karlsson | Scientific Advisor | Board & advisors |
85 more people are available in the full profile.
Complete people profiles for Colossal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Colossal
3 dated milestones of Colossal across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Colossal is founded.
- Funding First funding round of $15.0M.
- Funding Latest funding round, Series C, of $60.0M.
Web traffic of Colossal
The website of Colossal (colossal.com) receives about 241K visits a month and ranks #219,655 among all websites worldwide, #1,494 in Photography.
- Monthly visits241K
▲ 20.6% vs previous month
- Unique visitors93.1K
per month
- Global rank#219,655
among all websites
- Category rank#1,494
Hobbies and Leisure · Photography
- Bounce rate38%
- Pages per visit2.2
- Average visit53 sec
- DevicesDesktop 35% · Mobile 65%
Websites whose visitors overlap most with Colossal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
uchytel.com | uchytel.com | 100% | – | #783,127 | – |
| trendland.com | 81% | – | #776,291 | View details | |
colossalshop.com | colossalshop.com | 41% | – | – | – |
Latest news on Colossal
Complete news archive for Colossal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Colossal
10 companies that operate in the same segment as Colossal (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – | |
Diagnostic products including stable isotopes are supplied by the laboratory. | 1981 | Tewksbury, Massachusetts, United States | – | – | 284 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Colossal
Colossal was founded in 2021.
Colossal is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
Colossal is a funded company, having raised a total of $617.6M across 7 funding rounds to date. The company's 1st funding round was a Seed of $15M, raised on Sep 2021.
Colossal was founded in 2021 in Austin, United States, within the biotechnology sector. Genetic services are delivered through laboratory-based operations focused on genetic advancements. The company, co-founded by George M. Church, maintains its headquarters in Austin. Activities encompass research and application of genetic technologies, serving clients in the life sciences field across the United States.
Colossal offers De-Extinction Services and Conservation Partnerships.
Colossal has 35 investors. Key investors include Animoca Brands, Animal Capital, Twgglobal, Breyer Capital, and Bob Nelsen.
Colossal operates through Colossal Inc.
The website of Colossal receives about 241 thousand visits a month and ranks #219,655 among all websites worldwide.